Newsletter | November 7, 2026

11.07.26 -- Best Of October: AI, RWE, And Trial Workforce Gaps

OCTOBER’S ESSENTIAL READS: PEOPLE, DATA, AND SITE BURDEN

RWE Has A People Problem, Not A Data Volume Problem

AI can surface patterns in real-world data, but people still need to interpret them. James Richardson explains why analytical capacity is the bottleneck.

Why Duplicate Data Entry Is Burning Out Clinical Trial Sites

Elisa Cascade and David Vulcano explain how duplicate data entry slows enrollment, creates errors, and adds burden when sponsor and site systems clash.

Why Clinical Research Needs Its Own Federal Job Code

David Vulcano explains how a missing federal occupational classification limits workforce visibility, career pathways, and recognition in clinical research.

OCTOBER’S PRACTICAL INSIGHTS: AI, FEASIBILITY, AND RTSM

Where Agentic AI Is Finding A Role In Clinical Trials

Industry leaders examine agentic AI across startup, enrollment, and oversight, including human control, adoption challenges, and ways to measure impact.

How AI Simulations Can Test Trial Recruitment Feasibility

See how AI and synthetic patient data help teams test enrollment criteria, anticipate recruitment challenges, and refine protocols before trial launch.

Why Configurable RTSM Matters When Trial Protocols Change

Explore how configuration-driven RTSM can simplify amendments, reduce validation effort, and maintain traceability as trial requirements evolve.

OCTOBER’S RESOURCE PICKS: DOCUMENTS, VISITS, AND EVIDENCE

Exchange And Track Study Documents Across Trial Sites

Automated Visit Scheduling For Complex Global Trials

RWD And Evidence: A Guide For Trial Teams